Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells ; volume:21 ; number:1 ; day:1 ; month:9 ; year:2021 ; pages:1-13 ; date:12.2021
BMC cancer ; 21, Heft 1 (1.9.2021), 1-13, 12.2021
- Creator
-
Amaya, Celina
Luo, Shihua
Baigorri, Julio
Baucells, Rogelio
Smith, Elizabeth R.
Xu, Xiang-Xi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12885-021-08722-7
- URN
-
urn:nbn:de:101:1-2021111418512501277353
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Amaya, Celina
- Luo, Shihua
- Baigorri, Julio
- Baucells, Rogelio
- Smith, Elizabeth R.
- Xu, Xiang-Xi
- SpringerLink (Online service)
Other Objects (12)
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
The value of low-intensity pulsed ultrasound in reducing ovarian injury caused by chemotherapy in mice
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
High-intensity focused ultrasound therapy for pancreatic cancer
Synergistic cytotoxicity from cold atmospheric plasma and ultrasound in glioma cells
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
The value of low-intensity pulsed ultrasound in reducing ovarian injury caused by chemotherapy in mice
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
High-intensity focused ultrasound therapy for pancreatic cancer
Synergistic cytotoxicity from cold atmospheric plasma and ultrasound in glioma cells
DIAPH1 faciliates paclitaxel-mediated cytotoxicity of ovarian cancer cells
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Resistance to cisplatin and paclitaxel does not affect the sensitivity of human ovarian cancer cells to antiprogestin-induced cytotoxicity
The value of low-intensity pulsed ultrasound in reducing ovarian injury caused by chemotherapy in mice
TGFBI promoter hypermethylation correlating with paclitaxel chemoresistance in ovarian cancer
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Paclitaxel and cisplatin combined with intensity-modulated radiotherapy for upper esophageal carcinoma
Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells
High-intensity focused ultrasound therapy for pancreatic cancer